67152 Federal Register / Vol. 69, No. 220 / Tuesday, November 16, 2004 / Notices 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: Abubakar A. Shaikh, PhD, 

DVM, Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 6168, MSC 7892, Bethesda, MD 20892, 

(301) 435–1042, shaikha@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SEP to 

Review AOIC Member Conflicts. 

Date: November 24, 2004. 

Time: 11 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call).

Contact Person: Ranga V. Srinivas, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1167, srinivar@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel High 

Resolution Electron Microscopy. 

Date: November 29, 2004. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: Richard D. Rodewald, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5142, 

MSC 7840, Bethesda, MD 20892, (301) 435–

1024, rodewalr@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Neural 

Engineering. 

Date: December 1, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sofitel Lafayette Square Washington, 

806 15th Street, NW., Washington, DC 20005. 

Contact Person: Mary Custer, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4136, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1164, custerm@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Pelvic Floor 

Physiology. 

Date: December 1, 2004. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: M. Chris Langub, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4112, 

MSC 7814, Bethesda, MD 20892, (301) 496–

8551, langubm@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel PAR–03–137 

Topical Microbicides. 

Date: December 8–10, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, Washington, DC 20037. 

Contact Person: Ranga V. Srinivas, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1167, srinivar@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel ZRG1 ONC 

F (02) Gene Expression. 

Date: December 13, 2004. 

Time: 1:30 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call).

Contact Person: Marcia Litwack, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6206, 

MSC 7804, Bethesda, MD 20892, (301) 435–

1719, litwackm@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict—Neurogenesis. 

Date: December 14, 2004. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(telephone conference call). 

Contact Person: Carole L. Jelsema, PhD, 

Chief and Scientific Review Administrator, 

MDCN Scientific Review Group, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4146, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1248, jelsemac@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Pharmacogenetics and Bioinformatics. 

Date: December 14–15, 2004. 

Time: 5 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Four Points by Sheraton Bethesda, 

8400 Wisconsin Avenue, Bethesda, MD 

20814. 

Contact Person: Barbara Whitmarsh, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2206, 

MSC 7890, Bethesda, MD 20892, (301) 435–

4511, whitmarshb@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Angiotensin 

Receptors. 

Date: December 17, 2004. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(telephone conference call). 

Contact Person: Joyce C. Gibson, DSC, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4130, 

MSC 7814, Bethesda, MD 20892, (301) 435–

4522, gibsonj@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 RUS–

E (02) Renal Urology Special Member 

Conflicts Meeting. 

Date: December 20, 2004. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Aftab A. Ansari, PhD, 

Health Scientist Administrator, National 

Institutes of Health, Center for Scientific 

Review, 6701 Rockledge Drive, Room 4108, 

MSC 7814, Bethesda, MD 20892, (301) 435–

1173, ansaria@csr.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS)

Dated: November 8, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–25346 Filed 11–15–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration will publish 

periodic summaries of proposed 

projects. To request more information 

on the proposed projects or to obtain a 

copy of the information collection 

plans, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Federal Register / Vol. 69, No. 220 / Tuesday, November 16, 2004 / Notices 67153

National Survey on Drug Use and 

Health: Clinical Validation Study of the 

Substance Dependence and Abuse 

Measures—(OMB No. 0930–0231)—

Revision 

The Substance Abuse and Mental 

Health Services Administration’s 

(SAMHSA) National Survey on Drug 

Use and Health (NSDUH), formerly the 

National Household Survey on Drug 

Abuse, is a survey of the civilian, 

noninstitutionalized population of the 

United States 12 years old and older. 

The data are used to determine the 

prevalence of use of tobacco products, 

alcohol, illicit substances, and illicit use 

of prescription drugs. The results are 

used by SAMHSA, the Office of 

National Drug Control Policy, other 

Federal government agencies, and other 

organizations and researchers to 

establish policy, direct program 

activities, and better allocate resources. 

From 2001–2004, the NSDUH 

conducted the first phase (phase 1) of a 

two-phase Clinical Validation Study of 

the Substance Dependence and Abuse 

Measures. From 2005–2007 the NSDUH 

plans to conduct the second phase 

(Phase 2) of this study. Specific aims of 

the two-phase study are to achieve the 

best overarching format, and the best 

wording and ordering for the assessment 

questions. The goal is improved validity 

and reduced respondent burden. 

In phase 1 a field test was conducted. 

Half of all subjects in this field test were 

between 12 and 17, and half 18 years of 

age or older; subjects were recruited 

from the Research Triangle and the 

Triad areas of North Carolina through 

fliers and newspaper ads, and asked (1) 

demographic information and (2) 

questions from two self-administered 

sections of the NSDUH questionnaire: 

questions about the quantity and 

frequency of use of drugs and alcohol, 

and questions about symptoms of 

substance dependence and abuse. A 

semi-structured clinical interview was 

administered to these same subjects by 

a trained clinician to determine the 

presence or absence of substance 

dependence and abuse. The clinical 

instruments used to assess subjects were 

the substance abuse modules from the 

Structured Clinical Interview for DSM–

IV (SCID) (for adults) and the Kiddie 

Schedule for Affective Disorders and 

Schizophrenia (K–SADS ) (for those 

between 12 and 17 years of age). The 

correspondence of the diagnosis of 

substance dependence and abuse 

between the clinical and survey 

interview were compared. 

The results of this comparison from 

the field test in phase 1 indicated a lack 

of sufficient correspondence between 

the clinical and survey interview. 

Overall there was a strong tendency 

toward over reporting in the survey 

interview. Recommendations were 

made to revise specific questions. 

Problems with specific questions were 

identified and reasons for lack of 

correspondence were examined. 

Modifications to the NSDUH questions 

on substance dependence and abuse to 

achieve better correspondence are being 

made for phase 2 of the study. In order 

to reduce a tendency to over report 

some questions have been revised to be 

more specific. 

In Phase 2, a second clinical 

validation study will be conducted 

using the same procedures as Phase 1 

but with the revised questions on 

dependence or abuse. This will allow a 

determination of the correspondence 

(kappa) between the revised diagnosis 

obtained from the NSDUH substance 

dependence and abuse module and the 

diagnosis from the structured clinical 

interviews. Final revisions to the survey 

instrument will be made based on 

findings from Phase 2. All decisions 

about final revisions to the module will 

balance the need for correspondence 

across different groups. The following 

table summarizes the burden associated 

with phase two of the project.

Phase II Number of

respondents 

Responses 

per

respondent 

Hours per

response Total burden 

Adults: 

Screening .................................................................................................. 400 1 .08 32 

Screener and interview ............................................................................. 200 1 1.5 300 

Adolescents: 

Screening .................................................................................................. 200 1 1.5 300 

Screener and interview ............................................................................. 170 1 1.50 255 

Total ................................................................................................... 370 ........................ ........................ 887 

Send comments to Summer King, 

SAMHSA Reports Clearance Officer, 

Room 7–1044, 1 Choke Cherry Road, 

Rockville, MD 20850. Written comments 

should be received by January 18, 2005.

Dated: November 9, 2004. 

Anna Marsh, 

Executive Officer, SAMHSA.

[FR Doc. 04–25365 Filed 11–15–04; 8:45 am] 

BILLING CODE 4162–20–P

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[USCG–2004–19591] 

Collection of Information Under 

Review by Office of Management and 

Budget (OMB): OMB Control Numbers: 

1625–0005, 1625–0020, 1625–0029, 

1625–0031, 1625–0085, and 1625–0096

AGENCY: Coast Guard, DHS.

ACTION: Request for comments.

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

Coast Guard intends to seek the 

approval of OMB for the renewal or 

revision of six Information Collection 

Requests (ICRs). The ICRs comprise (1) 

1625–0005, Application and Permit to 

Handle Hazardous Materials; (2) 1625–

0020, Security Zones, Regulated 

Navigation Areas, and Safety Zones; (3) 

1625–0029, Self-propelled Liquefied 

Gas Vessels; (4) 1625–0031, Plan 

Approval and Records for Electrical 

Engineering Regulations—title 46 CFR 

subchapter J; (5) 1625–0085, 

Streamlined Inspection Program; and (6) 

1625–0096, Report of Oil or Hazardous 

Substance Discharge, and Report of 

Suspicious Maritime Activity. Before 

submitting the ICRs to OMB, the Coast 

Guard is inviting comments on them as 

described below.

DATES: Comments must reach the Coast 

Guard on or before January 18, 2005.

ADDRESSES: To make sure that your 

comments and related material do not